Healthcare Peptide Therapeutics Market | Page 2

The global peptide therapeutics market is segmented into application such as
cancer, cardiovascular, central nervous system, metabolic disorders, infection,
hematological disorders, gastrointestinal disorders, respiratory disorders and
acromegaly. Among these segments, cancer segment is projected to be the fastest
growing segment by 2024. Likely, rising demand for peptide therapeutics owing
to growing occurrence of long term diseases such as cancer is predicted to propel
the growth of global peptide therapeutics market. Moreover, rise in spending on
healthcare is yet another major growth driving the growth of peptide therapeutics
market.
Global peptide therapeutics market is projected to register a CAGR of 8.2% over
the forecast period i.e. 2016-2023. Moreover, the global peptide therapeutics
market is anticipated to reach at noteworthy revenue of USD 26.2 Billion by
2023. The market is expected to expand on the back of increasing investment in
healthcare sector by the government authorities.
The parenteral segment by route of administration is projected to grab the
biggest share in overall peptide therapeutics market by 2023. In the terms of
geography, highest demand for peptide therapy was seen from North-America.
Further, increasing aging population and favorable reimbursement policies are
some of the factors propelling the growth of peptide therapeutics market. Apart
from this, Asia-Pacific peptide therapeutics market is expected to expand at a
robust CAGR during the forecast period owing to rapid expansion of biotech
companies.
Increasing Geriatric Population
Increase in aging population across the globe is believed to trigger the prevalence
of diseases such as cardiac, cardiovascular and osteoporosis which is likely to
increase the burden on emerging economies, thus intensifying the demand for
peptide therapeutics so as to reduce the burden and minimize the health
expenditure.
Request For Free Sample Pages: https://www.researchnester.com/sample-
request/2/rep-id-180
Rising Healthcare Expenditure
Rising biotech companies and increasing healthcare spending by the government
authorities, rising prevalence of cancer and nervous system disorders are some of
Copyright © Research Nester
www.researchnester.com